Ophthalmic Steroids Drugs refer to the steroids drug for the Ophthalmic. A large class of important natural compounds are derived from steroids with a tetracyclic structure. These compounds are called steroids and they are found in all plants and animals. The most abundant steroid in animals is cholesterol C27H46O. The body can synthesize cholesterol, and it can easily absorb cholesterol from food through the intestinal wall. Cholesterol is related to the formation of gallstones, which also harden the arteries. Biochemical changes and degradation of cholesterol produce many steroids that are important in human biochemistry.

The global Ophthalmic Steroids Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Steroids Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Steroids Drug.

Report Scope

The Ophthalmic Steroids Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Steroids Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ophthalmic Steroids Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ophthalmic Steroids Drug Market Report

Report Metric	Details
Report Name	Ophthalmic Steroids Drug Market
CAGR	5%
Segment by Type	Uveitis Diabetic Macular Edema Allergic Conjunctivitis Keratitis Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Research Institute Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Steroids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ophthalmic Steroids Drug Market report?

Ans: The main players in the Ophthalmic Steroids Drug Market are Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International

What are the Application segmentation covered in the Ophthalmic Steroids Drug Market report?

Ans: The Applications covered in the Ophthalmic Steroids Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Research Institute, Others

What are the Type segmentation covered in the Ophthalmic Steroids Drug Market report?

Ans: The Types covered in the Ophthalmic Steroids Drug Market report are Uveitis, Diabetic Macular Edema, Allergic Conjunctivitis, Keratitis, Others

1 Ophthalmic Steroids Drug Market Overview

1.1 Product Overview and Scope of Ophthalmic Steroids Drug

1.2 Ophthalmic Steroids Drug Segment by Type

1.2.1 Global Ophthalmic Steroids Drug Market Value Comparison by Type (2024-2030)

1.2.2 Uveitis

1.2.3 Diabetic Macular Edema

1.2.4 Allergic Conjunctivitis

1.2.5 Keratitis

1.2.6 Others

1.3 Ophthalmic Steroids Drug Segment by Application

1.3.1 Global Ophthalmic Steroids Drug Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Research Institute

1.3.6 Others

1.4 Global Ophthalmic Steroids Drug Market Size Estimates and Forecasts

1.4.1 Global Ophthalmic Steroids Drug Revenue 2019-2030

1.4.2 Global Ophthalmic Steroids Drug Sales 2019-2030

1.4.3 Global Ophthalmic Steroids Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Ophthalmic Steroids Drug Market Competition by Manufacturers

2.1 Global Ophthalmic Steroids Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Ophthalmic Steroids Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Ophthalmic Steroids Drug Average Price by Manufacturers (2019-2024)

2.4 Global Ophthalmic Steroids Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ophthalmic Steroids Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ophthalmic Steroids Drug, Product Type & Application

2.7 Ophthalmic Steroids Drug Market Competitive Situation and Trends

2.7.1 Ophthalmic Steroids Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Steroids Drug Players Market Share by Revenue

2.7.3 Global Ophthalmic Steroids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ophthalmic Steroids Drug Retrospective Market Scenario by Region

3.1 Global Ophthalmic Steroids Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Ophthalmic Steroids Drug Global Ophthalmic Steroids Drug Sales by Region: 2019-2030

3.2.1 Global Ophthalmic Steroids Drug Sales by Region: 2019-2024

3.2.2 Global Ophthalmic Steroids Drug Sales by Region: 2025-2030

3.3 Global Ophthalmic Steroids Drug Global Ophthalmic Steroids Drug Revenue by Region: 2019-2030

3.3.1 Global Ophthalmic Steroids Drug Revenue by Region: 2019-2024

3.3.2 Global Ophthalmic Steroids Drug Revenue by Region: 2025-2030

3.4 North America Ophthalmic Steroids Drug Market Facts & Figures by Country

3.4.1 North America Ophthalmic Steroids Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Ophthalmic Steroids Drug Sales by Country (2019-2030)

3.4.3 North America Ophthalmic Steroids Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ophthalmic Steroids Drug Market Facts & Figures by Country

3.5.1 Europe Ophthalmic Steroids Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Ophthalmic Steroids Drug Sales by Country (2019-2030)

3.5.3 Europe Ophthalmic Steroids Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ophthalmic Steroids Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Ophthalmic Steroids Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Ophthalmic Steroids Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Ophthalmic Steroids Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Ophthalmic Steroids Drug Market Facts & Figures by Country

3.7.1 Latin America Ophthalmic Steroids Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Ophthalmic Steroids Drug Sales by Country (2019-2030)

3.7.3 Latin America Ophthalmic Steroids Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ophthalmic Steroids Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Ophthalmic Steroids Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Ophthalmic Steroids Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ophthalmic Steroids Drug Sales by Type (2019-2030)

4.1.1 Global Ophthalmic Steroids Drug Sales by Type (2019-2024)

4.1.2 Global Ophthalmic Steroids Drug Sales by Type (2025-2030)

4.1.3 Global Ophthalmic Steroids Drug Sales Market Share by Type (2019-2030)

4.2 Global Ophthalmic Steroids Drug Revenue by Type (2019-2030)

4.2.1 Global Ophthalmic Steroids Drug Revenue by Type (2019-2024)

4.2.2 Global Ophthalmic Steroids Drug Revenue by Type (2025-2030)

4.2.3 Global Ophthalmic Steroids Drug Revenue Market Share by Type (2019-2030)

4.3 Global Ophthalmic Steroids Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Ophthalmic Steroids Drug Sales by Application (2019-2030)

5.1.1 Global Ophthalmic Steroids Drug Sales by Application (2019-2024)

5.1.2 Global Ophthalmic Steroids Drug Sales by Application (2025-2030)

5.1.3 Global Ophthalmic Steroids Drug Sales Market Share by Application (2019-2030)

5.2 Global Ophthalmic Steroids Drug Revenue by Application (2019-2030)

5.2.1 Global Ophthalmic Steroids Drug Revenue by Application (2019-2024)

5.2.2 Global Ophthalmic Steroids Drug Revenue by Application (2025-2030)

5.2.3 Global Ophthalmic Steroids Drug Revenue Market Share by Application (2019-2030)

5.3 Global Ophthalmic Steroids Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bausch and Lomb

6.1.1 Bausch and Lomb Corporation Information

6.1.2 Bausch and Lomb Description and Business Overview

6.1.3 Bausch and Lomb Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio

6.1.5 Bausch and Lomb Recent Developments/Updates

6.2 Alimera Sciences

6.2.1 Alimera Sciences Corporation Information

6.2.2 Alimera Sciences Description and Business Overview

6.2.3 Alimera Sciences Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Alimera Sciences Ophthalmic Steroids Drug Product Portfolio

6.2.5 Alimera Sciences Recent Developments/Updates

6.3 Allergan

6.3.1 Allergan Corporation Information

6.3.2 Allergan Description and Business Overview

6.3.3 Allergan Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Allergan Ophthalmic Steroids Drug Product Portfolio

6.3.5 Allergan Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Corporation Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis AG Ophthalmic Steroids Drug Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Genentech

6.6.1 Genentech Corporation Information

6.6.2 Genentech Description and Business Overview

6.6.3 Genentech Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Genentech Ophthalmic Steroids Drug Product Portfolio

6.6.5 Genentech Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Ophthalmic Steroids Drug Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Bayer AG

6.8.1 Bayer AG Corporation Information

6.8.2 Bayer AG Description and Business Overview

6.8.3 Bayer AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bayer AG Ophthalmic Steroids Drug Product Portfolio

6.8.5 Bayer AG Recent Developments/Updates

6.9 Regeneron Pharmaceuticals

6.9.1 Regeneron Pharmaceuticals Corporation Information

6.9.2 Regeneron Pharmaceuticals Description and Business Overview

6.9.3 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio

6.9.5 Regeneron Pharmaceuticals Recent Developments/Updates

6.10 Valeant Pharmaceuticals International

6.10.1 Valeant Pharmaceuticals International Corporation Information

6.10.2 Valeant Pharmaceuticals International Description and Business Overview

6.10.3 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio

6.10.5 Valeant Pharmaceuticals International Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ophthalmic Steroids Drug Industry Chain Analysis

7.2 Ophthalmic Steroids Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ophthalmic Steroids Drug Production Mode & Process

7.4 Ophthalmic Steroids Drug Sales and Marketing

7.4.1 Ophthalmic Steroids Drug Sales Channels

7.4.2 Ophthalmic Steroids Drug Distributors

7.5 Ophthalmic Steroids Drug Customers

8 Ophthalmic Steroids Drug Market Dynamics

8.1 Ophthalmic Steroids Drug Industry Trends

8.2 Ophthalmic Steroids Drug Market Drivers

8.3 Ophthalmic Steroids Drug Market Challenges

8.4 Ophthalmic Steroids Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Regeneron Pharmaceuticals

Valeant Pharmaceuticals International

List of Tables

Table 1. Global Ophthalmic Steroids Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Ophthalmic Steroids Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Ophthalmic Steroids Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Ophthalmic Steroids Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Ophthalmic Steroids Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Ophthalmic Steroids Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Ophthalmic Steroids Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Ophthalmic Steroids Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Ophthalmic Steroids Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ophthalmic Steroids Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ophthalmic Steroids Drug, Product Type & Application

Table 12. Global Key Manufacturers of Ophthalmic Steroids Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ophthalmic Steroids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Steroids Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ophthalmic Steroids Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Ophthalmic Steroids Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Ophthalmic Steroids Drug Sales Market Share by Region (2019-2024)

Table 19. Global Ophthalmic Steroids Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Ophthalmic Steroids Drug Sales Market Share by Region (2025-2030)

Table 21. Global Ophthalmic Steroids Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Ophthalmic Steroids Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Ophthalmic Steroids Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Ophthalmic Steroids Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Ophthalmic Steroids Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Ophthalmic Steroids Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Ophthalmic Steroids Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Ophthalmic Steroids Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Ophthalmic Steroids Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Ophthalmic Steroids Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Ophthalmic Steroids Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Ophthalmic Steroids Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Ophthalmic Steroids Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Ophthalmic Steroids Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Ophthalmic Steroids Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Ophthalmic Steroids Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Ophthalmic Steroids Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Ophthalmic Steroids Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Ophthalmic Steroids Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Ophthalmic Steroids Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Ophthalmic Steroids Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Ophthalmic Steroids Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Ophthalmic Steroids Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Ophthalmic Steroids Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Ophthalmic Steroids Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Ophthalmic Steroids Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Ophthalmic Steroids Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Ophthalmic Steroids Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Ophthalmic Steroids Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Ophthalmic Steroids Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Ophthalmic Steroids Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Ophthalmic Steroids Drug Sales Market Share by Type (2019-2024)

Table 53. Global Ophthalmic Steroids Drug Sales Market Share by Type (2025-2030)

Table 54. Global Ophthalmic Steroids Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Ophthalmic Steroids Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Ophthalmic Steroids Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Ophthalmic Steroids Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Ophthalmic Steroids Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Ophthalmic Steroids Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Ophthalmic Steroids Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Ophthalmic Steroids Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Ophthalmic Steroids Drug Sales Market Share by Application (2019-2024)

Table 63. Global Ophthalmic Steroids Drug Sales Market Share by Application (2025-2030)

Table 64. Global Ophthalmic Steroids Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Ophthalmic Steroids Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Ophthalmic Steroids Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Ophthalmic Steroids Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Ophthalmic Steroids Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Ophthalmic Steroids Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Bausch and Lomb Corporation Information

Table 71. Bausch and Lomb Description and Business Overview

Table 72. Bausch and Lomb Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bausch and Lomb Ophthalmic Steroids Drug Product

Table 74. Bausch and Lomb Recent Developments/Updates

Table 75. Alimera Sciences Corporation Information

Table 76. Alimera Sciences Description and Business Overview

Table 77. Alimera Sciences Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Alimera Sciences Ophthalmic Steroids Drug Product

Table 79. Alimera Sciences Recent Developments/Updates

Table 80. Allergan Corporation Information

Table 81. Allergan Description and Business Overview

Table 82. Allergan Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Allergan Ophthalmic Steroids Drug Product

Table 84. Allergan Recent Developments/Updates

Table 85. Novartis AG Corporation Information

Table 86. Novartis AG Description and Business Overview

Table 87. Novartis AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis AG Ophthalmic Steroids Drug Product

Table 89. Novartis AG Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Ophthalmic Steroids Drug Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Genentech Corporation Information

Table 96. Genentech Description and Business Overview

Table 97. Genentech Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Genentech Ophthalmic Steroids Drug Product

Table 99. Genentech Recent Developments/Updates

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Pfizer Ophthalmic Steroids Drug Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Bayer AG Corporation Information

Table 106. Bayer AG Description and Business Overview

Table 107. Bayer AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Bayer AG Ophthalmic Steroids Drug Product

Table 109. Bayer AG Recent Developments/Updates

Table 110. Regeneron Pharmaceuticals Corporation Information

Table 111. Regeneron Pharmaceuticals Description and Business Overview

Table 112. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product

Table 114. Regeneron Pharmaceuticals Recent Developments/Updates

Table 115. Valeant Pharmaceuticals International Corporation Information

Table 116. Valeant Pharmaceuticals International Description and Business Overview

Table 117. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product

Table 119. Valeant Pharmaceuticals International Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Ophthalmic Steroids Drug Distributors List

Table 123. Ophthalmic Steroids Drug Customers List

Table 124. Ophthalmic Steroids Drug Market Trends

Table 125. Ophthalmic Steroids Drug Market Drivers

Table 126. Ophthalmic Steroids Drug Market Challenges

Table 127. Ophthalmic Steroids Drug Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Ophthalmic Steroids Drug

Figure 2. Global Ophthalmic Steroids Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ophthalmic Steroids Drug Market Share by Type in 2023 & 2030

Figure 4. Uveitis Product Picture

Figure 5. Diabetic Macular Edema Product Picture

Figure 6. Allergic Conjunctivitis Product Picture

Figure 7. Keratitis Product Picture

Figure 8. Others Product Picture

Figure 9. Global Ophthalmic Steroids Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Ophthalmic Steroids Drug Market Share by Application in 2023 & 2030

Figure 11. Hospital Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Online Pharmacies

Figure 14. Research Institute

Figure 15. Others

Figure 16. Global Ophthalmic Steroids Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Ophthalmic Steroids Drug Market Size (2019-2030) & (US$ Million)

Figure 18. Global Ophthalmic Steroids Drug Sales (2019-2030) & (K Units)

Figure 19. Global Ophthalmic Steroids Drug Average Price (US$/Unit) & (2019-2030)

Figure 20. Ophthalmic Steroids Drug Report Years Considered

Figure 21. Ophthalmic Steroids Drug Sales Share by Manufacturers in 2023

Figure 22. Global Ophthalmic Steroids Drug Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Ophthalmic Steroids Drug Players: Market Share by Revenue in 2023

Figure 24. Ophthalmic Steroids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Ophthalmic Steroids Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Ophthalmic Steroids Drug Sales Market Share by Country (2019-2030)

Figure 27. North America Ophthalmic Steroids Drug Revenue Market Share by Country (2019-2030)

Figure 28. United States Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Ophthalmic Steroids Drug Sales Market Share by Country (2019-2030)

Figure 31. Europe Ophthalmic Steroids Drug Revenue Market Share by Country (2019-2030)

Figure 32. Germany Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Ophthalmic Steroids Drug Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Ophthalmic Steroids Drug Revenue Market Share by Region (2019-2030)

Figure 39. China Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. China Taiwan Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Ophthalmic Steroids Drug Sales Market Share by Country (2019-2030)

Figure 49. Latin America Ophthalmic Steroids Drug Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Ophthalmic Steroids Drug Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Ophthalmic Steroids Drug Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. UAE Ophthalmic Steroids Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Ophthalmic Steroids Drug by Type (2019-2030)

Figure 59. Global Revenue Market Share of Ophthalmic Steroids Drug by Type (2019-2030)

Figure 60. Global Ophthalmic Steroids Drug Price (US$/Unit) by Type (2019-2030)

Figure 61. Global Sales Market Share of Ophthalmic Steroids Drug by Application (2019-2030)

Figure 62. Global Revenue Market Share of Ophthalmic Steroids Drug by Application (2019-2030)

Figure 63. Global Ophthalmic Steroids Drug Price (US$/Unit) by Application (2019-2030)

Figure 64. Ophthalmic Steroids Drug Value Chain

Figure 65. Ophthalmic Steroids Drug Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cell Signaling Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32I5919

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Keytruda Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4J8284

Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Fc Fusion Protein for Eye Diseases Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11F10758

Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Nuclear Medicine Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8W14462

Sun May 19 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions